Idil Esen
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis.
Journal: Journal of autoimmunity
Published: June 30, 2023
Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients.
Journal: Frontiers in immunology
Published: March 30, 2023
Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 09, 2022
Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Journal: RMD open
Published: August 05, 2022
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply.
Journal: Rheumatology (Oxford, England)
Published: February 03, 2022
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment.
Journal: Journal of clinical medicine
Published: September 06, 2021
Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
Journal: Rheumatology (Oxford, England)
Published: May 31, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026